JiangXi Tianxin Pharmaceutical Co (SHSE:603235) EV-to-EBIT : 16.09 (As of May. 26, 2024)

JiangXi Tianxin Pharmaceutical Co EV-to-EBIT Chart

JiangXi Tianxin Pharmaceutical Co Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial											18.39	17.82	17.98	14.68	13.39

Competitive Comparison of JiangXi Tianxin Pharmaceutical Co's EV-to-EBIT

For the Packaged Foods subindustry, JiangXi Tianxin Pharmaceutical Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JiangXi Tianxin Pharmaceutical Co's EV-to-EBIT Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, JiangXi Tianxin Pharmaceutical Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where JiangXi Tianxin Pharmaceutical Co's EV-to-EBIT falls into.

JiangXi Tianxin Pharmaceutical Co EV-to-EBIT Calculation

JiangXi Tianxin Pharmaceutical Co's EV-to-EBIT for today is calculated as:

JiangXi Tianxin Pharmaceutical Co's current Enterprise Value is ¥9,475 Mil.
JiangXi Tianxin Pharmaceutical Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥589 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JiangXi Tianxin Pharmaceutical Co  (SHSE:603235) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

JiangXi Tianxin Pharmaceutical Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

JiangXi Tianxin Pharmaceutical Co's Enterprise Value for the quarter that ended in Mar. 2024 was ¥7,882 Mil.
JiangXi Tianxin Pharmaceutical Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥589 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JiangXi Tianxin Pharmaceutical Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of JiangXi Tianxin Pharmaceutical Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

JiangXi Tianxin Pharmaceutical Co (SHSE:603235) Business Description